Tumorigenesis is a major hidden danger to human health, with over nine million people
worldwide dying from tumors annually. About two-thirds of tumors are caused by persistent …

Currently, seven viruses, namely Epstein-Barr virus (EBV), Kaposi's sarcoma-associated
herpes virus (KSHV), high-risk human papillomaviruses (HPVs), Merkel cell polyomavirus …

Epstein-Barr virus (EBV) infection occurs by distinct mechanisms across different cell types.
EBV infection of B cells in vitro minimally requires 5 viral glycoproteins and 2 cellular …

The Epstein–Barr virus (EBV) is associated with a variety of human malignancies, including
Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma and gastric cancers …

After being recognized for their anti-neoplastic properties at the beginning of the last century,
viruses are again being considered for use as therapeutic agents against cancer. Certain …

Oncogenic viruses are among the apparent causes of cancer-associated mortality. It was
estimated that 12% to 15% of human malignancies are linked to oncoviruses. Although …

Approximately 15–20% of global cancer incidence is causally linked to viral infection, yet the
low incidence of cancers in healthy infected individuals suggests that malignant conversion …

Tremendous advances have been made in developing oncolytic viruses (OVs) in the last
few years. By taking advantage of current knowledge in cancer biology and virology, specific …

To infect mammalian cells, all infectious viruses must cross a common set of biophysical
membrane barriers to gain access to the cell. The virus capsid proteins attach to a host cell …

Viruses enter host cells in order to complete their life cycles and have evolved to exploit host
cell structures, regulatory factors and mechanisms. The virus and host cell interactions have …